Cyclopenthiazide

No registered brands found for this active ingredient.

No food notes on record for this active ingredient.

• 1-benzylimidazoleMODERATE

  1-benzylimidazole may decrease the antihypertensive activities of Cyclopenthiazide.

  Expert view
• 1alpha-Hydroxyvitamin D5MODERATE

  The risk or severity of hypercalcemia can be increased when Cyclopenthiazide is combined with 1alpha-Hydroxyvitamin D5.

  Expert view
• 1alpha,24S-Dihydroxyvitamin D2MODERATE

  The risk or severity of hypercalcemia can be increased when Cyclopenthiazide is combined with 1alpha,24S-Dihydroxyvitamin D2.

  Expert view
• 2,5-Dimethoxy-4-ethylamphetamineMODERATE

  2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Cyclopenthiazide.

  Expert view
• 4-Bromo-2,5-dimethoxyamphetamineMODERATE

  4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cyclopenthiazide.

  Expert view
• 4-MethoxyamphetamineMODERATE

  4-Methoxyamphetamine may decrease the antihypertensive activities of Cyclopenthiazide.

  Expert view
• 7,8-Dichloro-1,2,3,4-tetrahydroisoquinolineMODERATE

  7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Cyclopenthiazide.

  Expert view
• AbacavirMODERATE

  Cyclopenthiazide may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.

  Expert view
• AbaloparatideMODERATE

  Abaloparatide may increase the hypotensive activities of Cyclopenthiazide.

  Expert view
• AbediterolMODERATE

  The risk or severity of hypokalemia can be increased when Abediterol is combined with Cyclopenthiazide.

  Expert view